NRSN Forecast — Price Prediction for 2025. Should I Buy NRSN?
1-Day-Price-Prediction
-5.28%
1-Week Prediction
+1.53%
1-Month Prediction
+7.53%
2026 Prediction
+148.54%
2030 Prediction
+236.42%
Based on our advanced algorithm, we predict that NRSN stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $0.84, while the 1-week outlook suggests a value of $0.9. For the 1-month forecast, we project a price of $0.96. Looking further ahead, our 2026 projection estimates a value of $2.21, with a long-term 2030 forecast reaching $2.99. Stay informed and make strategic decisions with our data-driven insights!
Should I Buy Neurosense Therapeutics Ltd Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. NRSN has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
NRSN stock price ended at $0.84 on Monday, after losing-5.62%
The Neurosense Therapeutics Ltd stock price decreased by -5.62% on the last trading day (15 Dec 2025), dropping from 0.8995 to 0.89. Throughout the last trading session, the stock experienced a fluctuation of 4.59% , ranging from a day low of $0.86 to a day high of 0.8995. The price has declined in 7 of the last 10 days, resulting in a total change of -25.21% during this period. On the last day, trading volume increase by -181.44K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 152.25K shares were traded, amounting to approximately 134.02K.
NRSN Technical Signals
NRSN(Neurosense Therapeutics Ltd Corp) has 4 buy signals and 3 sell signals now. The current trend is an uptrend starting from 2025-11-24. The total price change during this trend is -18.35%. Recently, the price has dropped while volume droped, indicating a potential rebound signal. The average turnover of NRSN over the last 5 trading days is 396.34K. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
NRSN Moving Average Analysis
Neurosense Therapeutics Ltd's overall moving average trend leans more bearish as of Monday, December 15, 2025, with 4 negative signals and 0 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $1.27, and $1.42. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $0.81, and $0.66. A break-down below any of these levels will issue sell signals.
NRSN Short Selling Analysis
The short sale ratio of Neurosense Therapeutics Ltd(NRSN) as of 10 Dec 2025 is 34.41%, rising from last trading day. With increasing price from 0.95 to 0.88. The short sell activity indicate that short sellers may be anticipating further declines.
Technical Signal
Technical Signals Summary
Sell
3
Buy
4
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
5.746
Bullish
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 < -100
-142.039
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
3.652
Bullish
Williams %R (14 days)
WILLR_14 < -80
-98.553
Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-0.143
Bearish
Momentum (10 days)
MOM_10 < 0
-0.304
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-0.0517
Bearish
NRSN Stock Forecast
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
Month
Min. Price
Avg. Price
Max. Price
Potential ROI
Jan 2026
$1.76
$2.06
$2.19
+0.74%
Feb 2026
$2.14
$2.15
$2.44
+5.16%
Mar 2026
$2.04
$2.11
$2.40
+3.39%
Apr 2026
$2.07
$2.17
$2.46
+6.29%
May 2026
$1.68
$1.82
$2.05
-10.75%
Jun 2026
$2.16
$2.46
$2.58
+20.38%
Jul 2026
$1.46
$1.85
$2.26
-9.44%
Aug 2026
$2.45
$2.46
$2.78
+20.75%
Sep 2026
$1.99
$2.05
$2.35
+0.73%
Oct 2026
$1.82
$1.82
$2.18
-10.75%
Nov 2026
$1.69
$1.82
$1.94
-10.75%
Dec 2026
$2.00
$2.21
$2.41
+8.43%
In 2026, Neurosense Therapeutics Ltd (NRSN) is anticipated to change hands in a trading channel between $1.46 and $2.78.
Neurosense Therapeutics Ltd Stock Forecast 2026
Jan 2026: NRSN Stock Forecast
Potential ROI: 0.74%
In Jan 2026, Neurosense Therapeutics Ltd's value is forecasted to reach an average price of $2.06. The price is predicted to fluctuate between a low of $1.76 and a high of $2.19.
Feb 2026: NRSN Stock Forecast
Potential ROI: 5.16%
In Feb 2026, Neurosense Therapeutics Ltd's value is forecasted to reach an average price of $2.15. The price is predicted to fluctuate between a low of $2.14 and a high of $2.44.
Mar 2026: NRSN Stock Forecast
Potential ROI: 3.39%
In Mar 2026, Neurosense Therapeutics Ltd's value is forecasted to reach an average price of $2.11. The price is predicted to fluctuate between a low of $2.04 and a high of $2.40.
Apr 2026: NRSN Stock Forecast
Potential ROI: 6.29%
In Apr 2026, Neurosense Therapeutics Ltd's value is forecasted to reach an average price of $2.17. The price is predicted to fluctuate between a low of $2.07 and a high of $2.46.
May 2026: NRSN Stock Forecast
Potential ROI: -10.75%
In May 2026, Neurosense Therapeutics Ltd's value is forecasted to reach an average price of $1.82. The price is predicted to fluctuate between a low of $1.68 and a high of $2.05.
Jun 2026: NRSN Stock Forecast
Potential ROI: 20.38%
In Jun 2026, Neurosense Therapeutics Ltd's value is forecasted to reach an average price of $2.46. The price is predicted to fluctuate between a low of $2.16 and a high of $2.58.
Jul 2026: NRSN Stock Forecast
Potential ROI: -9.44%
In Jul 2026, Neurosense Therapeutics Ltd's value is forecasted to reach an average price of $1.85. The price is predicted to fluctuate between a low of $1.46 and a high of $2.26.
Aug 2026: NRSN Stock Forecast
Potential ROI: 20.75%
In Aug 2026, Neurosense Therapeutics Ltd's value is forecasted to reach an average price of $2.46. The price is predicted to fluctuate between a low of $2.45 and a high of $2.78.
Sep 2026: NRSN Stock Forecast
Potential ROI: 0.73%
In Sep 2026, Neurosense Therapeutics Ltd's value is forecasted to reach an average price of $2.05. The price is predicted to fluctuate between a low of $1.99 and a high of $2.35.
Oct 2026: NRSN Stock Forecast
Potential ROI: -10.75%
In Oct 2026, Neurosense Therapeutics Ltd's value is forecasted to reach an average price of $1.82. The price is predicted to fluctuate between a low of $1.82 and a high of $2.18.
Nov 2026: NRSN Stock Forecast
Potential ROI: -10.75%
In Nov 2026, Neurosense Therapeutics Ltd's value is forecasted to reach an average price of $1.82. The price is predicted to fluctuate between a low of $1.69 and a high of $1.94.
Dec 2026: NRSN Stock Forecast
Potential ROI: 8.43%
In Dec 2026, Neurosense Therapeutics Ltd's value is forecasted to reach an average price of $2.21. The price is predicted to fluctuate between a low of $2.00 and a high of $2.41.
NRSN Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Neurosense Therapeutics Ltd(NRSN), our algorithm predicts NRSN's 1-month price at $1.00, with an 12.5%upwardshift. Using a similarity score up to 92.52%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Neurosense Therapeutics Ltd (NRSN.O) stock, as of Sunday, December 14, 2025 , forecasts a 12.5% change over the next month, based on its high correlation with GSM.O stock patterns. The similarity between their price movements over the analyzed periods is 92.52%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
NRSN
No data
GSM
Up: 12.5%Similarity: 92.52%
Name
Similarity
Up/Down
GSM.O
92.52%
+12.50%
CGC.O
92.40%
+21.37%
MIDD.O
90.96%
+7.01%
ADTN.O
90.23%
+10.50%
NRSN Seasonality Analysis
Based on NRSN's historical stock price data across all years, the probability of a positive return in December is25.00%, suggesting it maynotbe an ideal month to invest in NRSN. In contrast,Juneoffers the highest probability of positive returns at80.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Neurosense Therapeutics Ltd (NRSN.O) stock in June has the highest probability of a positive return (80.00%), while July has the lowest probability (0.00%).
Performance Seasonality
The chart shows Neurosense Therapeutics Ltd. (NRSN)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy Neurosense Therapeutics Ltd (NRSN.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. NRSN has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Neurosense Therapeutics Ltd (NRSN.O) stock in a year?
The radar chart shows that buying Neurosense Therapeutics Ltd (NRSN.O) stock in June has the highest probability of a positive return (80.00%), while July has the lowest probability (0.00%).
How has Neurosense Therapeutics Ltd. (NRSN)'s stock price performed over the past three years?
NRSN's stock price fell by -42.28% in 2023,increased by 50.00% in 2024, and went down by 26.96%in 2025.
Is NRSN a buy based on overall technical signals summary?
NRSN has 4 buy signals and 3 sell signals now. Overall the technical rating for NRSN is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of NRSN.
What is the trend of Neurosense Therapeutics Ltd (NRSN)'s moving average?
Neurosense Therapeutics Ltd's overall moving average trend leans more bearish as of December 15 2025, with 4 negative signals and 0 positive signal.
What is price prediction for NRSN stock next month?
The price prediction chart for Neurosense Therapeutics Ltd (NRSN.O) stock, as of December 14 2025, forecasts a 12.5% change over the next month, based on its high correlation with GSM stock patterns. The similarity between their price movements over the analyzed periods is 92.52%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2026 for Neurosense Therapeutics Ltd (NRSN) Stock?
In Dec 2026, Neurosense Therapeutics Ltd's value is forecasted to reach an average price of $2.21. The price is predicted to fluctuate between a low of $2.00 and a high of $2.41.
What is price prediction 2030 for Neurosense Therapeutics Ltd (NRSN) Stock?
In Dec 2030, Neurosense Therapeutics Ltd's value is forecasted to reach an average price of $2.99. The price is predicted to fluctuate between a low of $2.82 and a high of $3.56.
Negative
